Does very early, sustained moderate hypothermia in patients with severe traumatic brain injury, increase favourable neurological outcomes? A randomised controlled trial.
Does erythropoetin alpha 40,000u s/c given once a week for 3 weeks or until ICU discharge, improve favourable neurological outcomes. A double blinded randomised controlled trial.
A multi centre, randomised controlled trial of early goal-directed therapy in patients presenting to the emergency department with severe sepsis in Australasia.
Feasibility of allocating the freshest available red blood cells to critically ill patients: a double blinded randomised controlled pilot study.
A prospective, multicentre single cohort study of mechanical ventilation practices.
An observational study of sedation practices in intensive care.
A prospective randomised controlled trial of operative stabilisation of fractured ribs in trauma patients.
A registry of patients admitted to intensive care with serious or life-threatening illnesses related to Influenza A.
Sub-studies within Infinite:
A pilot study that aims to establish whether oesophageal pressure readings can be a reliable reflection of transpleural pressure transmission in ventilated intensive care patients.
A study of staircase recruitment manoeuvres in ventilated patients with acute lung injury.
A retrospective cohort study that aims to identify possible contributing factors to the development of pressure injuries in trauma patients in the intensive care unit.
A randomised double blind placebo-controlled trial that aims to examine whether exogenous melatonin will improve sleep in ICU patients with sleep disturbances.
A randomised, double-blind, multi-centre placebo controlled trial of dexmedetomidine for patients with agitation and delirium in the intensive care unit.
A phase ll randomised controlled trial of atorvastatin therapy in intensive care patients with severe sepsis.
A randomized, double-blind, placebo-controlled, multicenter, Phase 3 study of drorecogin alfa (activated) administered as a continuous 96-hour infusion to adult patients with septic shock.
A systematic program of point prevalence studies to facilitate ICU research in Australia and New Zealand by performing multiple observational point prevalence studies on a particular day.